<code id='FAA6C23697'></code><style id='FAA6C23697'></style>
    • <acronym id='FAA6C23697'></acronym>
      <center id='FAA6C23697'><center id='FAA6C23697'><tfoot id='FAA6C23697'></tfoot></center><abbr id='FAA6C23697'><dir id='FAA6C23697'><tfoot id='FAA6C23697'></tfoot><noframes id='FAA6C23697'>

    • <optgroup id='FAA6C23697'><strike id='FAA6C23697'><sup id='FAA6C23697'></sup></strike><code id='FAA6C23697'></code></optgroup>
        1. <b id='FAA6C23697'><label id='FAA6C23697'><select id='FAA6C23697'><dt id='FAA6C23697'><span id='FAA6C23697'></span></dt></select></label></b><u id='FAA6C23697'></u>
          <i id='FAA6C23697'><strike id='FAA6C23697'><tt id='FAA6C23697'><pre id='FAA6C23697'></pre></tt></strike></i>

          explore

          explore

          author:Wikipedia    Page View:34248
          Photo illustration based on photograph of The University of Texas MD Anderson Cancer Center in Houston, Texas in 2022
          Photo illustration: STAT; Photo: Adobe

          Three years ago, Jamie Lin, an early-career nephrologist at MD Anderson Cancer Center, made findings that could potentially help both save the kidneys of cancer patients and propel her career as a physician-scientist hoping to one day run her own lab. It was a promising start, but that’s when Lin says one of the Texas institute’s most powerful researchers interfered.

          Lin alleges in a lawsuit that prominent oncologist Padmanee Sharma derailed the publication of papers based on Lin’s work, threatened to undermine her fledgling career, and made defamatory comments about her in retaliation for resisting making Sharma an author on a paper and saying the senior researcher had made no substantial contribution to it.

          advertisement

          “Having this and another paper taken — what would’ve been important papers for my career,” Lin told STAT in an interview. “I’m sure that my career in research has just fallen off a cliff.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more
          FDA rejects Alnylam's heart disease treatment over insufficient data
          FDA rejects Alnylam's heart disease treatment over insufficient data

          KristofferTripplaar/SipaUSA/APTheFoodandDrugAdministrationrejectedanAlnylamPharmaceuticals’therapyfo

          read more
          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more

          Doctors increasingly discourage vaping amid mounting health concerns

          3:24Amansmokesane-cigarettesSTOCKPHOTO/GettyImagesDoctorsareincreasinglydiscouragingpeoplefromusinge